Position in JNJ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$415,240
+$253,666 QoQ
Shares Held
1,635
+147.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#3,892
of 4,676 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HIGHLINE WEALTH PARTNERS LLC holds $1,353,065 across 14 Drug Manufacturers - General names. JNJ ranks #1 (30.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
1,635 | $415,240 | |
| 2 | LLY |
ELI LILLY & Co
|
180 | $215,897 | |
| 3 | AMGN |
Amgen Inc
|
429 | $155,349 | |
| 4 | MRK |
Merck & Co., Inc.
|
932 | $119,762 | |
| 5 | ABBV |
AbbVie Inc.
|
419 | $105,437 | |
| 6 | AZN |
Astrazeneca PLC
|
314 | $59,540 | |
| 7 | PFE |
Pfizer Inc
|
2,356 | $56,732 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
446 | $56,347 |
All Filings in JNJ
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $415,240 | 1,635 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $161,574 | 661 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $125,204 | 605 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $81,770 | 441 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $42,311 | 277 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $41,791 | 252 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $24,006 | 166 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $31,277 | 193 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $26,601 | 182 | Shares | Sole | 2024-10-28 | |
| 2024-03-31 | $16,293 | 103 | Shares | Sole | 2024-10-28 | |
| 2023-12-31 | $24,921 | 159 | Shares | Sole | 2024-10-29 | |
| 2023-09-30 | $34,109 | 219 | Shares | Sole | 2024-10-29 | |
| 2023-06-30 | $36,248 | 219 | Shares | Sole | 2024-10-29 | |
| 2023-03-31 | $29,450 | 190 | Shares | Sole | 2024-10-29 | |
| 2022-12-31 | $53,348 | 302 | Shares | Sole | 2024-10-29 | |
| 2022-09-30 | $36,429 | 223 | Shares | Sole | 2024-10-29 | |
| No filing history on record for this holder in this stock. | ||||||